TickerFacts.

Lexeo Therapeutics, Inc. (LXEO): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

53.65M
Year ended 2025-12-31
+220.4%
3-year compound annual growth
2022-12-31: 1.63M2023-12-31: 5.35M2024-12-31: 31.79M2025-12-31: 53.65M53.65M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3153.65M+68.8%2026-03-30, From 2025-01-01
2024-12-3131.79M+493.7%2026-03-30, From 2024-01-01
2023-12-315.35M+228.4%2025-03-24, From 2023-01-01
2022-12-311.63Mn/a2024-03-11, From 2022-01-01